Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet

Stephen L. Slocum, John J. Skoko, Nobunao Wakabayashi, Susan Aja, Masayuki Yamamoto, Thomas W. Kensler, Dionysios V. Chartoumpekis

Research output: Contribution to journalArticle

Abstract

The Keap1/Nrf2 pathway, known to regulate the expression of a series of cytoprotective and antioxidant genes, has been studied in the context of obesity and type 2 diabetes; diseases that are characterized by chronic oxidative stress. There is increasing evidence, however, that the transcription factor Nrf2 can crosstalk with pathways not directly related to cytoprotection. Our present work focuses on the effect of Nrf2 on hepatic gluconeogenesis and lipogenesis, two metabolic processes which are dysregulated in the obese/diabetic state. To this end, a genetic mouse model of Nrf2 pathway activation was used (Keap1-hypo; both Keap1 alleles are hypomorphic) and was exposed to a 3-month high-fat diet along with the relevant control wild-type mice. The Keap1-hypo mice were partially protected from obesity, had lower fasting glucose and insulin levels and developed less liver steatosis compared to the wild-type. Key gluconeogenic and lipogenic enzymes were repressed in the Keap1-hypo livers with concomitant activated Ampk signaling. Primary Keap1-hypo hepatocyte cultures also show increased Ampk signaling and repressed glucose production. In conclusion, increased Keap1/Nrf2 signaling in the liver is accompanied by repressed gluconeogenesis and lipogenesis that can, at least partially, explain the ameliorated diabetic phenotype in the Keap1-hypo mice.

LanguageEnglish (US)
Pages57-65
Number of pages9
JournalArchives of Biochemistry and Biophysics
Volume591
DOIs
StatePublished - Feb 1 2016

Fingerprint

High Fat Diet
Nutrition
Liver
Chemical activation
Fats
Lipogenesis
Gluconeogenesis
Glucose
Oxidative stress
Obesity
Medical problems
Crosstalk
Cytoprotection
Genetic Models
Transcription Factors
Fatty Liver
Antioxidants
Genes
Insulin
Type 2 Diabetes Mellitus

Keywords

  • Ampk
  • Diabetes
  • Gluconeogenesis
  • Keap1
  • Lipogenesis
  • Nrf2

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet. / Slocum, Stephen L.; Skoko, John J.; Wakabayashi, Nobunao; Aja, Susan; Yamamoto, Masayuki; Kensler, Thomas W.; Chartoumpekis, Dionysios V.

In: Archives of Biochemistry and Biophysics, Vol. 591, 01.02.2016, p. 57-65.

Research output: Contribution to journalArticle

Slocum, Stephen L. ; Skoko, John J. ; Wakabayashi, Nobunao ; Aja, Susan ; Yamamoto, Masayuki ; Kensler, Thomas W. ; Chartoumpekis, Dionysios V./ Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet. In: Archives of Biochemistry and Biophysics. 2016 ; Vol. 591. pp. 57-65
@article{2d7d9d796c5b4492916ca29d9c2aba6d,
title = "Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet",
abstract = "The Keap1/Nrf2 pathway, known to regulate the expression of a series of cytoprotective and antioxidant genes, has been studied in the context of obesity and type 2 diabetes; diseases that are characterized by chronic oxidative stress. There is increasing evidence, however, that the transcription factor Nrf2 can crosstalk with pathways not directly related to cytoprotection. Our present work focuses on the effect of Nrf2 on hepatic gluconeogenesis and lipogenesis, two metabolic processes which are dysregulated in the obese/diabetic state. To this end, a genetic mouse model of Nrf2 pathway activation was used (Keap1-hypo; both Keap1 alleles are hypomorphic) and was exposed to a 3-month high-fat diet along with the relevant control wild-type mice. The Keap1-hypo mice were partially protected from obesity, had lower fasting glucose and insulin levels and developed less liver steatosis compared to the wild-type. Key gluconeogenic and lipogenic enzymes were repressed in the Keap1-hypo livers with concomitant activated Ampk signaling. Primary Keap1-hypo hepatocyte cultures also show increased Ampk signaling and repressed glucose production. In conclusion, increased Keap1/Nrf2 signaling in the liver is accompanied by repressed gluconeogenesis and lipogenesis that can, at least partially, explain the ameliorated diabetic phenotype in the Keap1-hypo mice.",
keywords = "Ampk, Diabetes, Gluconeogenesis, Keap1, Lipogenesis, Nrf2",
author = "Slocum, {Stephen L.} and Skoko, {John J.} and Nobunao Wakabayashi and Susan Aja and Masayuki Yamamoto and Kensler, {Thomas W.} and Chartoumpekis, {Dionysios V.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.abb.2015.11.040",
language = "English (US)",
volume = "591",
pages = "57--65",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet

AU - Slocum,Stephen L.

AU - Skoko,John J.

AU - Wakabayashi,Nobunao

AU - Aja,Susan

AU - Yamamoto,Masayuki

AU - Kensler,Thomas W.

AU - Chartoumpekis,Dionysios V.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The Keap1/Nrf2 pathway, known to regulate the expression of a series of cytoprotective and antioxidant genes, has been studied in the context of obesity and type 2 diabetes; diseases that are characterized by chronic oxidative stress. There is increasing evidence, however, that the transcription factor Nrf2 can crosstalk with pathways not directly related to cytoprotection. Our present work focuses on the effect of Nrf2 on hepatic gluconeogenesis and lipogenesis, two metabolic processes which are dysregulated in the obese/diabetic state. To this end, a genetic mouse model of Nrf2 pathway activation was used (Keap1-hypo; both Keap1 alleles are hypomorphic) and was exposed to a 3-month high-fat diet along with the relevant control wild-type mice. The Keap1-hypo mice were partially protected from obesity, had lower fasting glucose and insulin levels and developed less liver steatosis compared to the wild-type. Key gluconeogenic and lipogenic enzymes were repressed in the Keap1-hypo livers with concomitant activated Ampk signaling. Primary Keap1-hypo hepatocyte cultures also show increased Ampk signaling and repressed glucose production. In conclusion, increased Keap1/Nrf2 signaling in the liver is accompanied by repressed gluconeogenesis and lipogenesis that can, at least partially, explain the ameliorated diabetic phenotype in the Keap1-hypo mice.

AB - The Keap1/Nrf2 pathway, known to regulate the expression of a series of cytoprotective and antioxidant genes, has been studied in the context of obesity and type 2 diabetes; diseases that are characterized by chronic oxidative stress. There is increasing evidence, however, that the transcription factor Nrf2 can crosstalk with pathways not directly related to cytoprotection. Our present work focuses on the effect of Nrf2 on hepatic gluconeogenesis and lipogenesis, two metabolic processes which are dysregulated in the obese/diabetic state. To this end, a genetic mouse model of Nrf2 pathway activation was used (Keap1-hypo; both Keap1 alleles are hypomorphic) and was exposed to a 3-month high-fat diet along with the relevant control wild-type mice. The Keap1-hypo mice were partially protected from obesity, had lower fasting glucose and insulin levels and developed less liver steatosis compared to the wild-type. Key gluconeogenic and lipogenic enzymes were repressed in the Keap1-hypo livers with concomitant activated Ampk signaling. Primary Keap1-hypo hepatocyte cultures also show increased Ampk signaling and repressed glucose production. In conclusion, increased Keap1/Nrf2 signaling in the liver is accompanied by repressed gluconeogenesis and lipogenesis that can, at least partially, explain the ameliorated diabetic phenotype in the Keap1-hypo mice.

KW - Ampk

KW - Diabetes

KW - Gluconeogenesis

KW - Keap1

KW - Lipogenesis

KW - Nrf2

UR - http://www.scopus.com/inward/record.url?scp=84952333224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952333224&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2015.11.040

DO - 10.1016/j.abb.2015.11.040

M3 - Article

VL - 591

SP - 57

EP - 65

JO - Archives of Biochemistry and Biophysics

T2 - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

ER -